Clinical trial
Treatment of AIDS Vacuolar Myelopathy With Methionine
NCT00032695 · National Institute of Neurological Disorders and Stroke (NINDS), NIH · Completed
Key facts
| NCT number | NCT00032695 |
|---|---|
| Title | Treatment of AIDS Vacuolar Myelopathy With Methionine |
| Lead sponsor | National Institute of Neurological Disorders and Stroke (NINDS), NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Myelopathy, AIDS-Myelopathy, AIDS Vacuolar Myelopathy |
| Intervention type | Drug |
| Interventions | methionine |
| Enrollment | 56 |
| First posted | Mar 29, 2002 |
| Last update posted | May 15, 2006 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: